BlackRock’s Nanobiotix NBTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$343 Buy
+11
New +$424 ﹤0.01% 5724
2025
Q1
– Sell
-51,484
Closed -$148K – 5487
2024
Q4
$148K Sell
51,484
-177,435
-78% -$710K ﹤0.01% 4682
2024
Q3
$1.32M Sell
228,919
-10,089
-4% -$52.6K ﹤0.01% 4117
2024
Q2
$1.2M Sell
239,008
-14,446
-6% -$87.1K ﹤0.01% 4132
2024
Q1
$1.65M Buy
253,454
+34,939
+16% +$247K ﹤0.01% 4067
2023
Q4
$1.59M Buy
+218,515
New +$1.38M ﹤0.01% 4117

Other funds holding NBTX

BlackRock's NBTX Position: Q3 2026 in Review

BlackRock opened a new position in Nanobiotix (NBTX) in Q3 2026: 11 shares worth $343. The stake represents ﹤0.01% of the portfolio and ranks #5724 among its holdings. This is a return to the name: BlackRock previously reported a position in NBTX as recently as Q4 2024.

BlackRock first reported a position in NBTX in Q4 2023 and has held it in 6 quarters since. The position peaked at $1.65M in Q1 2024. 14 funds tracked by Wall St. Rank hold NBTX as of Q3 2026.

  • BlackRock held 11 shares of Nanobiotix worth $343 as of Q3 2026.
  • Nanobiotix was a new BlackRock position in Q3 2026.
  • Nanobiotix made up ﹤0.01% of BlackRock's portfolio in Q3 2026, its #5724 holding.
  • BlackRock first reported a position in Nanobiotix in Q4 2023 and has held it in 6 quarters since.
  • BlackRock's Nanobiotix position peaked at $1.65M in Q1 2024.
  • 14 funds tracked by Wall St. Rank held Nanobiotix as of Q3 2026.

Based on BlackRock's 13F filing for Q3 2026, filed 13 Nov 2026.